Vanberra Signal
Free trial

attyloid

Curated by Signal

Quantitative detection of single oligomers and aggregates for CNS disorders

Life Sciences Technologyattyloid.com

Overview

Quantitative detection of single oligomers and aggregates for CNS disorders. It offers proprietary sFIDA technology for the early detection of neurodegenerative diseases like Alzheimer's and Parkinson's that integrates the precision of selective immunoassays with the sensitivity of fluorescence microscopy to count single particles.

Key facts

Founded
2018
Headquarters
Dusseldorf, Germany
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

14 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Ontosight

    Provider of AI-based solutions for drug discovery & development

    Life Sciences TechnologyEschborn, Germany

  • ColoAlert

    Provider of colorectal cancer screening test by analysing DNA

    Life Sciences TechnologyGermany

  • GlucoSmart

    Glucose monitoring system

    Life Sciences TechnologyBobingen, Germany

About attyloid

What does attyloid do?

Quantitative detection of single oligomers and aggregates for CNS disorders.

Where is attyloid headquartered?

attyloid is headquartered in Dusseldorf, Germany.

When was attyloid founded?

attyloid was founded in 2018.

Which sector is attyloid in?

attyloid operates in Life Sciences Technology.

Who are attyloid's competitors?

Companies similar to attyloid include Ontosight, ColoAlert, and GlucoSmart.